Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Prestige Consumer Healthcare (PBH) Long-Term Debt Repayments: 2009-2024

Historic Long-Term Debt Repayments for Prestige Consumer Healthcare (PBH) over the last 14 years, with Dec 2024 value amounting to $60.0 million.

  • Prestige Consumer Healthcare's Long-Term Debt Repayments fell 7.69% to $60.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $210.0 million, marking a year-over-year decrease of 8.70%. This contributed to the annual value of $135.0 million for FY2025, which is 40.00% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Long-Term Debt Repayments stood at $60.0 million for Q4 2024, which was up 50.00% from $40.0 million recorded in Q3 2024.
  • In the past 5 years, Prestige Consumer Healthcare's Long-Term Debt Repayments ranged from a high of $475.0 million in Q3 2021 and a low of -$352.0 million during Q1 2020.
  • Its 3-year average for Long-Term Debt Repayments is $45.8 million, with a median of $47.5 million in 2022.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Long-Term Debt Repayments slumped by 882.22% in 2020, and later soared by 541.89% in 2021.
  • Prestige Consumer Healthcare's Long-Term Debt Repayments (Quarterly) stood at $74.0 million in 2020, then surged by 541.89% to $50.0 million in 2021, then tumbled by 70.00% to $15.0 million in 2022, then skyrocketed by 333.33% to $65.0 million in 2023, then declined by 7.69% to $60.0 million in 2024.
  • Its Long-Term Debt Repayments was $60.0 million in Q4 2024, compared to $40.0 million in Q3 2024 and $35.0 million in Q2 2024.